Growth-promoting effect of recombinant human growth hormone and stanozolol in girls with Turner syndrome
Fang Junmin , Ning Cong , Shu Dan , Wei Hong , Lin Hanhua , Wang Mudi
Current Medical Science ›› 1999, Vol. 19 ›› Issue (1) : 63
Growth-promoting effect of recombinant human growth hormone and stanozolol in girls with Turner syndrome
Ten girls with Turner syndrome were treated with a combination therapy of recombinant human growth hormone (R-hGH) and low dose stanozolol for a period of 8 to 36 months. The results showed that when compared with the growth rate before the treatment, the growth rates after treatment with R-hGH and stanozolol showed a sustained increase, reaching 9. 0±l.9 cm/year during the first year of treatment; the height age increase by 2. 5±0.8 years while the bone age increase were 1. 0±0. 7 years; and the predicted final adult height at the end of the first year of the treatment increased to 149. 4±6. 1 cm compared to their original mean of 142. 8 ±4. 2 cm. We are led to conclude that therapy with R-hGH in combination with stanozolol can increase the growth velocity and significantly increase the predicted adult height of children with Turner syndrome.
recombinant human growth hormone (R-hGH) / Turner syndrome / growth velocity / predicted adult height
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
Turner, 1995, 13(6):378 |
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
/
| 〈 |
|
〉 |